Delivery Order SPE2DB22D2007-SPE2DB24FH8FM
Award Date 12/29/23
Potential Completion Date 1/23/24
Potential Value $7.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $21,261.50 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This federal contract award, valued at $8,504.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tecentriq, a 840 mg/14 mL vial medication, with a completion date of February 27, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,293.34, is a Delivery Order for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty pharmaceutical product. The award has an ultimate completion date of December 20, 2024 and is structured as a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $33,173.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Tecentriq, a cancer immunotherapy medication, with a completion date of January 2, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of parent company Cencora, Inc. The $8,016.30 fixed-price delivery order is for the supply of TECENTRIQ 840 MG/14 ML VIAL 14ML, a pharmaceutical product. The award supports the DLA's mission to provide logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $17,009.24 firm fixed-price delivery order is for the pharmaceutical product TECENTRIQ 840 MG/14 ML VIAL 14ML. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 19, 2026, with performance executed from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- This federal contract award, valued at $26,019.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "TECVAYLI 153 MG/1.7 ML VIAL 1.7ML" and has a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $9,344.66 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials on January 28, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The delivery order is scheduled for completion by February 19, 2026, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. This contract represents a task order under...
- This federal contract award, valued at $7,171.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty...